Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|March 27, 2019
An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimizationThomas Jouve, Johan Noble, Lionel Rostaing, et al.
Expert Opinion on Pharmacotherapy|November 20, 2022
Imlifidase therapy: exploring its clinical usesLionel Rostaing, Johan Noble, Paolo Malvezzi, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 5, 2018
Desensitization in the Setting of HLA-Incompatible Kidney TransplantPaolo Malvezzi, Thomas Jouve, Johan Noble, et al.
Expert Review of Clinical Pharmacology|November 16, 2020
pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppressionEloi Chevallier, Thomas Jouve, Lionel Rostaing, et al.
Journal of Clinical Medicine|October 13, 2021
Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature ReviewJules Weinhard, Johan Noble, Thomas Jouve, et al.
Frontiers in Immunology|February 22, 2020
Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney TransplantationJohan Noble, Thomas Jouve, Paolo Malvezzi, et al.
Expert Review of Clinical Immunology|January 25, 2019
Belatacept in kidney transplantation and its limitationsJohan Noble, Thomas Jouve, Bénédicte Janbon, et al.
Journal of Personalized Medicine|December 23, 2023
Adverse Drug Events after Kidney TransplantationLionel Rostaing, Thomas Jouve, Florian Terrec, et al.
Pageof 10